Drug research ignores stable or pleasurable use — And that’s a problem
[27.08.2019]
In the United States and beyond, drug research ignores most people who use drugs. While the large majority of people who use drugs (PWUD) do not suff ...
Drugs: researchers shouldn’t just focus on the harms
[14.02.2019]
Most drug research focuses on the harms they cause, but studying the pleasure they provide will improve our understanding of why people use them. Amo ...
People take drugs for pleasure and fun – so why do we drown that out by obsessing over the harm?
[31.01.2019]
Are you one of the 10 million people who have used drugs like cannabis or cocaine? Make no mistake, drugs are fun. They must be, given the scale of d ...
How legal weed could change the future of sex
[08.02.2015]
Weed’s got a dirty little secret: It holds the power to transform our sex lives. Our ancient ancestors believed it, researchers in the 70s and 80s tr ...
The real driver behind most drug use is pleasure, not dependence
[18.04.2013]
Harm minimisation, harm reduction, drug-related harm, drug overdose, addiction: these are the dominant narratives that are used when we talk about dr ...
Refine selection with
cannabis ecstasy harm reduction legalization NIDA pleasure reclassification scientific research substance-use disorder taxation treatment US drug policy ::
Select another tag
10-year Review 1998 UNGASS 2005 CND debate 2016 UNGASS 2019 HLM activism afghanistan africa albania alternative development alternatives to policing amnesty amphetamine amsterdam appellation of origin argentina asean ATS australia austria ayahuasca bahamas ballot 2012 banking barbados belgium belize bermuda bhang bolivia brazil brownfield doctrine burma caa california cambodia canada cannabinoids cannabis cannabis clubs cannabis industry caribbean caricom cbd oil central america chile china civil society CND coca cocaine coffee shop cognitive decline colombia colorado compulsary detention conflict conventions corporate capture corruption costa rica crack craft cannabis crime czech republic dark net death penalty decertification decriminalization deforestation denmark drug checking drug consumption rooms drug courts drug markets drug policy index drug testing drug tourism drug trade e-cigarettes e-joint ecstasy ecuador egypt el salvador environment eradication essential medicines estonia eswatini ethiopia european drug policy expert advisory group extrajudicial killings fair trade fentanyl france fumigation gateway theory georgia germany ghana global commission greece guatemala guatemala initiative harm reduction hemp heroin heroin assisted treatment HIV/AIDS home cultivation honduras human rights ICC illinois incarceration INCB india indigenous rights indonesia informal drug policy dialogues inter se modification iran ireland israel italy jamaica japan kava kazakhstan kenya ketamine khat kratom kyrgyzstan laos latin american debate law enforcement lebanon legal highs legalization lesotho local customization luxembourg malawi malaysia malta medical cannabis mental health methamphetamine mexico Mid-Term Review mild stimulants money laundering morocco naloxone negotiations nepal netherlands new york new zealand NIDA nigeria nitrous oxide norway NPS opinion polls opioids opium oregon overdose kits pakistan panama paraguay pardon patents peace peru peyote philippines pilot project pleasure poland police pacification portugal potency precursors prevention prison situation prohibition proportionality psychedelics psychosis puerto rico racism reclassification recriminalisation regulation russia sacramental use safe supply safer crack scheduling scientific research sdg security senegal sentencing singapore social justice somalia south africa spain st lucia st vincent and grenadines substance-use disorder substitution treatment sweden switzerland synthetic cannabinoids taxation teen use thailand thresholds tobacco industry traditional growers tramadol treatment trinidad & tobago tunisia UK UN Common Position UN drug control UNGASS UNODC uruguay US drug policy vaping venezuela vietnam violence WHO world drug report yemen
